Semaglutide
Semaglutide operates by simulating a hormone known as glucagon-like peptide (GLP-1), which primarily targets the brain. This hormone’s role is to reduce appetite and curb cravings, thus helping manage one’s food intake. Interestingly, every time we eat, our body naturally releases a particular hormone that induces a feeling of fullness. This medication cleverly mimics this sensation, further enhancing its effectiveness. By doing so, not only does it decrease appetite, but it also slows down stomach emptying, extending the duration of the satiated state and ultimately reducing overall caloric intake.
The medication will be administered in office once per week and dosage will increase as needed, once you have reached your goal weight the dose will be adjusted to maintain your weight.
Tirzepatide
Tirzepatide is a dual agonist for two natural gut hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By mimicking the actions of these hormones increases insulin release, reduces glucagon levels: Glucagon is a hormone that raises blood sugar, so reducing its levels further aids in blood sugar control.Slows gastric emptying: This helps you feel fuller for longer, reducing appetite and food intake.Signals satiety to the brain: It interacts with GLP-1 receptors in the brain to reduce hunger and cravings
The medication will be administered in office or at home once per week and dosage will increase as needed, once you have reached your goal weight the dose will be adjusted to maintain your weight.
